Answer to Question 1
1,2,4
Rationale 1: Abruptly discontinuing beta blockers may result in acute resurgence of symptoms such as hypertension.
Rationale 2: Abruptly discontinuing beta blockers may result in acute resurgence of symptoms such as dysrhythmia.
Rationale 3: Abruptly discontinuing beta blockers should not have an immediate effect on urinary output.
Rationale 4: Abruptly discontinuing beta blockers may result in chest pain.
Rationale 5: Abruptly discontinuing beta blockers should not result in pulmonary complications.
Global Rationale: Abruptly discontinuing beta blockers may result in acute resurgence of symptoms such as hypertension, dysrhythmia, and the development of chest pain. Abruptly discontinuing beta blockers should not have an immediate effect on urinary output and should not result in pulmonary complications.
Answer to Question 2
2
Rationale 1: Although headache is a side effect, it is not the priority.
Rationale 2: Enalapril (Vasotec) may produce a first-dose phenomenon resulting in profound hypotension, which may result in syncope.
Rationale 3: Enalapril (Vasotec) does not affect sodium levels.
Rationale 4: Enalapril (Vasotec) is more likely to cause hyperkalemia, not hypokalemia.
Global Rationale: Enalapril (Vasotec) may produce a first-dose phenomenon resulting in profound hypotension, which may result in syncope. Enalapril (Vasotec) is more likely to cause hyperkalemia, not hypokalemia. Enalapril (Vasotec) does not affect sodium levels. Although headache is a side effect, it is not as big a priority as profound hypotension.